Reyoung Pharmaceutical Co., Ltd
瑞洋製薬株式会社
Ruiyang Pharmaceutical Co., Ltd.は、研究開発、生産、販売を統合した総合的な現代製薬会社です。現在、従業員数は 5,000 名を超え、敷地面積は 120 万平方メートルです。国家ハイテク企業、国家バイオ医薬品産業化基幹企業、国家技術革新実証企業である。同社の主な事業収益は長年にわたり、国内製薬産業上位 100 社のうち上位 50 社にランクインしています。
- Type
- manufacturer (our classification of the record, not a statement by the company)
- Role
- Manufacturer
- Location
- Shandong, China
- Website
- https://www.reyoung.cn
- Categories
- 医薬品製造, サプリメントとウェルネス
Listed in a source registry
What is established and what is not
No facet of this company has been investigated yet. The facts below are collected records, not an assessment: nothing here confirms manufacturing, ownership or trading status beyond what each record literally says.
Verified facts
- product-authorised-for-sale (green), checked 2026-08-20 NAFDAC Greenbook, Nigeria - register of authorised products (manufacturer named on the authorisation)
- registered-manufacturer (green), checked 2026-08-21 Superintendencia de Regulacion Sanitaria de El Salvador, listado de productos farmaceuticos con registro sanitario vigente
- gmp-certified (green), effective since 2025-02-22 EudraGMDP, EU register of GMP certificates (EMA)
Import rules for these goods
- Food supplements sold in the EU follow Directive 2002/46/EC: most member states require a notification to the national authority before the first sale. European Commission (supplements)
- Medicines imported into the EU must come from a site holding an EU GMP certificate, and the importer needs a manufacturing/import authorisation. European Medicines Agency (GMP)